- Home
- FNWB vs DRRX Comparison
FNWB vs DRRX Comparison
Compare FNWB & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- DRRX
- Stock Information
- Founded
- FNWB 1923
- DRRX 1998
- Country
- FNWB United States
- DRRX United States
- Employees
- FNWB N/A
- DRRX N/A
- Industry
- FNWB Banks
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- FNWB Finance
- DRRX Health Care
- Exchange
- FNWB Nasdaq
- DRRX Nasdaq
- Market Cap
- FNWB 67.7M
- DRRX 59.3M
- IPO Year
- FNWB 2015
- DRRX 2000
- Fundamental
- Price
- FNWB $7.06
- DRRX $1.96
- Analyst Decision
- FNWB Hold
- DRRX Hold
- Analyst Count
- FNWB 1
- DRRX 1
- Target Price
- FNWB $12.00
- DRRX N/A
- AVG Volume (30 Days)
- FNWB 42.2K
- DRRX 525.3K
- Earning Date
- FNWB 10-28-2025
- DRRX 08-12-2025
- Dividend Yield
- FNWB 3.94%
- DRRX N/A
- EPS Growth
- FNWB N/A
- DRRX N/A
- EPS
- FNWB N/A
- DRRX N/A
- Revenue
- FNWB $48,874,000.00
- DRRX $1,657,000.00
- Revenue This Year
- FNWB $35.06
- DRRX N/A
- Revenue Next Year
- FNWB $13.06
- DRRX $673.00
- P/E Ratio
- FNWB N/A
- DRRX N/A
- Revenue Growth
- FNWB N/A
- DRRX N/A
- 52 Week Low
- FNWB $6.05
- DRRX $0.48
- 52 Week High
- FNWB $12.10
- DRRX $2.64
- Technical
- Relative Strength Index (RSI)
- FNWB 27.85
- DRRX 76.60
- Support Level
- FNWB $6.98
- DRRX $1.86
- Resistance Level
- FNWB $7.93
- DRRX $1.96
- Average True Range (ATR)
- FNWB 0.31
- DRRX 0.03
- MACD
- FNWB -0.09
- DRRX -0.04
- Stochastic Oscillator
- FNWB 5.52
- DRRX 90.91
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.